• 検索結果がありません。

Changes in Plasma Concentrations of Vitronectin in Patients with Diabetic

N/A
N/A
Protected

Academic year: 2022

シェア "Changes in Plasma Concentrations of Vitronectin in Patients with Diabetic"

Copied!
8
0
0

読み込み中.... (全文を見る)

全文

(1)

Acta Medica Okayama

Volume 48, Issue 3 1994 Article 4

J UNE 1994

Changes in Plasma Concentrations of Vitronectin in Patients with Diabetic

Nephropathy

Shigeru Morioka

Hirofumi Makino

Kenichi Shikata

Zensuke Ota

∗∗

Okayama University,

Okayama University,

Okayama Univeristy,

∗∗Okayama University,

Copyright c1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.

(2)

Changes in Plasma Concentrations of Vitronectin in Patients with Diabetic

Nephropathy

Shigeru Morioka, Hirofumi Makino, Kenichi Shikata, and Zensuke Ota

Abstract

To investigate the role of vitronectin in the progression of diabetic nephropathy, plasma con- centrations of vitronectin were measured by enzyme-linked immunosorbent assay in patients with diabetes mellitus and compared with normal control subjects. In diabetic patients with normoalbu- minuria and microalbuminuria, plasma concentrations of vitronectin were significantly higher than those of control subjects. Plasma concentrations of vitronectin in diabetic patients with chronic renal failure were significantly lower than those with normal renal function. There was a signifi- cant positive correlation between plasma concentration of vitronectin and blood platelet counts. In the early stage of diabetic nephropathy, vitronectin may be increased caused by synthesis from ac- tivated platelets. With progression of diabetic nephropathy, plasma vitronectin may be decreased because of accumulation in sclerotic glomeruli and arteriosclerotic lesions. In conclusion, the plasma concentration of vitronectin appears to be an important marker for the progression of dia- betic nephropathy.

KEYWORDS:vitronectin(S-protein), diabetic nephropathy, hypertension, chronic renal failure, enzyme-linked immunosorbent assay (ELISA)

PMID: 7524268 [PubMed - indexed for MEDLINE]

Copyright (C) OKAYAMA UNIVERSITY MEDICAL SCHOOL

(3)

1 Morioka et al.: Changes in Plasma Concentrations of Vitronectin in Patients

Produced by The Berkeley Electronic Press, 1994

(4)

2 Acta Medica Okayama, Vol. 48 [1994], Iss. 3, Art. 4

http://escholarship.lib.okayama-u.ac.jp/amo/vol48/iss3/4

(5)

3 Morioka et al.: Changes in Plasma Concentrations of Vitronectin in Patients

Produced by The Berkeley Electronic Press, 1994

(6)

4 Acta Medica Okayama, Vol. 48 [1994], Iss. 3, Art. 4

http://escholarship.lib.okayama-u.ac.jp/amo/vol48/iss3/4

(7)

5 Morioka et al.: Changes in Plasma Concentrations of Vitronectin in Patients

Produced by The Berkeley Electronic Press, 1994

(8)

6 Acta Medica Okayama, Vol. 48 [1994], Iss. 3, Art. 4

http://escholarship.lib.okayama-u.ac.jp/amo/vol48/iss3/4

参照

関連したドキュメント

肝線維化進展も抑制された。これらのことから、EPA は線維化を伴った脂肪性肝 炎の進展を抑制することが示唆された。 4.脂肪性肝炎は、肝線維化進展によって治療の難しい肝硬変へと進行するので、

原  著 〔東女医大誌 第64巻 第1号頁・48∼53 平成6年1月〕

Efficient Spatial Resource Management for Broadband MIMO Systems Abstract_要旨.. Thesis

(続紙 2 ) (論文審査の結果の要旨) 近年の分子遺伝学の進展によって家畜の経済形質に関与する遺伝子や分子マー

Keywords : hemodialysis patient, resting energy expenditure, physical activity level, serum albumin, poor nutritional status.. Received for publication August 1, 2005

Purpose: This study was performed to create a structural model of the effect of vascular access construction for maintenance of dialysis and how it influences the acceptance of

The structural model on the effect of vascular access construction in dialysis acceptance in patients with diabetic nephropathy.

The area under the receiver operating characteristics curves showed a positive discrimination threshold for intersti- tial fluid glucose of minimally invasive interstitial